Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects
As mitochondrial-targeted strategies advance toward clinical application, functional biomarkers of mitochondrial activity are emerging as important tools for predicting treatment response
By managing your blood sugar, adopting healthy habits, and seeking medical advice when needed, you can minimize the likelihood of complications
Rybelsus is approved as a type 2 diabetes tablet, not as a dedicated weight-loss drug
Glucagon-Like Peptide-1 Receptor Agonists and Muscle Mass Effects
Compounded drugs are not FDA approved, and the semaglutide shortage-related enforcement-discretion periods ended in 2025